21 May 2009
Impact of pancreas transplantation on the quality of life of diabetic renal transplant recipients
J Ziaja, D Bożek-Pająk, A Kowalik, R Król, L CierpkaAnn Transplant 2009; 14(1): 45-45 :: ID: 880364
Abstract
Background: The aim of simultaneous pancreas and kidney transplantation (SPK) performed in patients with insulin dependent diabetes mellitus (IDDM) and chronic renal failure (CRF) is to increase their health status, survival and the quality of life (QOL). However, SPK is related to an increased risk of postoperative complications compared to kidney transplantation alone (KTA). The aim of the study was to compare QOL of patients with IDDM and CRF subjected to SPK or KTA.
Material/Methods: Twenty patients after successful SPK with good function of both grafts as well as 16 patients after KTA and those who lost pancreatic graft shortly after SPK were analyzed. Minimal observation time was 6 months. QOL was evaluated using Polish version of Kidney Disease and Quality of Lifeâ„¢ Short Form (KDQOL-SFâ„¢).
Results: Observation time in SPK group was shorter than in KTA group (25 vs. 45 months). Analyzed groups did not differ in regard to patients' age during transplantation, duration of diabetes and dialysis treatment before transplantation. Patients after SPK reported higher QOL in regard to the effects of kidney disease and pain (87 vs. 78% and 100 vs. 62% respectively). Moreover, tendencies towards statistical significance were observed in differences between the groups in regard to cognitive function, physical function and general health (93 vs. 80%, 90 vs. 80% i 60 vs. 47% respectively).
Conclusions: QOL of patients with IDDM and CRF subjected to successful SPK is higher in regard to selected parameters evaluated in KDQOL-SFâ„¢ compared to patients subjected to KTA.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






